Quick Answer
GILEAD SCIENCES, INC. reported Operating Income Loss of $10.02 billion for the year ending 2025.
- GILEAD SCIENCES, INC. showed an increase of +503.0% in Operating Income Loss from 2024 to 2025.
- This data is from GILEAD SCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2010: $1.16 billion | Q2 2010: $992.63 million | Q3 2010: $979.07 million | Q1 2011: $901.97 million | Q2 2011: $1.02 billion | Q3 2011: $1.00 billion | Q1 2012: $800.19 million | Q2 2012: $1.06 billion | Q3 2012: $1.04 billion | Q1 2013: $1.03 billion | Q2 2013: $1.15 billion | Q3 2013: $1.15 billion | Q1 2014: $3.04 billion | Q2 2014: $4.41 billion | Q3 2014: $3.48 billion | Q1 2015: $5.37 billion | Q2 2015: $5.62 billion | Q3 2015: $5.59 billion | Q1 2016: $4.65 billion | Q2 2016: $4.54 billion | Q3 2016: $4.40 billion | Q1 2017: $3.77 billion | Q2 2017: $4.25 billion | Q3 2017: $3.81 billion | Q1 2018: $2.15 billion | Q2 2018: $2.28 billion | Q3 2018: $2.62 billion | Q1 2019: $2.24 billion | Q2 2019: $2.43 billion | Q3 2019: -$1.47 billion | Q1 2020: $2.40 billion | Q2 2020: -$2.98 billion | Q3 2020: $2.00 billion | Q1 2021: $2.89 billion | Q2 2021: $2.25 billion | Q3 2021: $3.84 billion | Q1 2022: $197.00 million | Q2 2022: $2.03 billion | Q3 2022: $2.84 billion | Q1 2023: $1.71 billion | Q2 2023: $1.67 billion | Q3 2023: $2.62 billion | Q1 2024: -$4.32 billion | Q2 2024: $2.64 billion | Q3 2024: $888.00 million | Q1 2025: $2.24 billion | Q2 2025: $2.47 billion | Q3 2025: $3.33 billion.
- Over the full 18 years of available data (2008 to 2025), GILEAD SCIENCES, INC.'s Operating Income Loss has grown by 274.2%.
- Historical annual values: Fiscal year 2025: $10.02 billion | Fiscal year 2024: $1.66 billion | Fiscal year 2023: $7.61 billion | Fiscal year 2022: $7.33 billion | Fiscal year 2021: $9.92 billion | Fiscal year 2020: $4.07 billion | Fiscal year 2019: $4.29 billion | Fiscal year 2018: $8.20 billion | Fiscal year 2017: $14.12 billion | Fiscal year 2016: $17.63 billion | Fiscal year 2015: $22.19 billion | Fiscal year 2014: $15.27 billion | Fiscal year 2013: $4.52 billion | Fiscal year 2012: $4.01 billion | Fiscal year 2011: $3.79 billion | Fiscal year 2010: $3.96 billion | Fiscal year 2009: $3.53 billion | Fiscal year 2008: $2.68 billion.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: